A Princeton-led team of researchers from the University, MIT, Harvard, and Editas Medicine developed and applied a new method to understand the activity of cellular genes involved in correcting DNA damage, paving the way for dramatic improvements to genome-editing technologies. These advances are described in a pair of papers that appeared online Oct. 14 and Oct. 20, 2021, in the journal "Cell."